REFERENCES
- Weatherall DJ, Clegg JB. The Thalassaemia Syndromes, 4th ed. Oxford: Blackwell Science, 2001.
- Cao A. Carrier screening and genetic counseling in β-thalassemia. Int J Hematol. 2002;76(Suppl 2):105–113.
- Taylor SM, Parobek CM, Fairhurst RM. Haemoglobinopathies and the clinical epidemiology of malaria: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(6):457–468.
- Denic S, Nicholls MG. Genetic benefits of consanguinity through selection of genotypes protective against malaria. Hum Biol. 2007;79(2):145–158.
- Bittles AH, Black ML. The impact of consanguinity on neonatal and infant health. Early Hum Dev. 2010;86(11):737–741.
- Bittles AH, Black ML. Evolution in health and medicine Sackler colloquium: consanguinity, human evolution, and complex diseases. Proc Natl Acad Sci USA. 2010;107(Suppl 1):1779–1786.
- Ahmed S, Saleem M, Modell B, Petrou M. Screening extended families for genetic hemoglobin disorders in Pakistan. N Engl J Med. 2002;347(15):1162–1168.
- Al-Gazali LI, Bener A, Abdulrazzaq YM, Micallef R, Al-Khayat AI, Gaber T. Consanguineous marriages in the United Arab Emirates. J Biosoc Sci. 1997;29(4):491–497.
- Agouti I, Merono F, Bonello-Palot N, Badens C. Analytical evaluation of the Capillarys 2 Flex piercing for routine haemoglobinopathies diagnosis. Int J Lab Hematol. 2013;35(2):217–221.
- Public Health and Policy Health Authority Abu Dhabi. Premarital screening and counseling program: Premarital Screening Standards. Version 0.9. Abu Dhabi: Health Authority of Abu Dhabi, 2010.
- Gillespie JH. Population Genetics: A Concise Guide. Baltimore: The John Hopkins University Press, 1998.
- White JM, Byrne M, Richards R, Buchanan T, Katsoulis E, Weerasingh K. Red cell genetic abnormalities in Peninsular Arabs: sickle haemoglobin, G6PD deficiency, and α and β thalassaemia. J Med Genet. 1986;23(3):245–251.
- Memish ZA, Saeedi MY. Six-year outcome of the national premarital screening and genetic counseling program for sickle cell disease and β-thalassemia in Saudi Arabia. Ann Saudi Med. 2011;31(3):229–235.
- Al-Riyami A, Ebrahim GJ. Genetic blood disorders survey in the Sultanate of Oman. J Trop Pediatr. 2003;49(Suppl 1):i1–20.
- Al-Arrayed S, Hafadh N, Amin S, Al-Mukhareq H, Sanad H. Student screening for inherited blood disorders in Bahrain. East Mediterr Health J. 2003;9(3):344–352.
- Miller CJ, Dunn EV, Berg B, Abdouni SF. A hematological survey of preschool children of the United Arab Emirates. Saudi Med J. 2003;24(6):609–613.
- Heard-Bey F. The tribal society of the UAE and its traditional economy In: Al Abed I, Hellyer P, Eds. United Arab Emirates: A New Perspective. London: Trident Press. 2001:98–116.
- Denic S, Souid AK, Nagelkerke N, Showqi S, Balhaj G. Erythrocyte reference values in Emirati people with and without α+ thalassemia. BMC Blood Disord. 2011;11:1.
- Denic S, Showqi S, Klein C, Takala M, Nagelkerke N, Agarwal MM. Prevalence, phenotype and inheritance of benign neutropenia in Arabs. BMC Blood Disord. 2009;9:3.
- Quaife R, Al-Gazali L, Abbes S, et al. The spectrum of β thalassaemia mutations in the UAE national population. J Med Genet. 1994;31(1):59–61.
- Baysal E. Molecular basis of β-thalassemia in the United Arab Emirates. Hemoglobin. 2011;35(5–6):581–588.
- Baysal E. Molecular heterogeneity of β-thalassemia in the United Arab Emirates. Community Genet. 2005;8(1):35–39.
- El-Kalla S, Mathews AR. Molecular characterization of β-thalassemia in the United Arab Emirates. Hemoglobin. 1993;17(4):355–362.
- El-Kalla S, Mathews AR. A significant β-thalassemia heterogeneity in the United Arab Emirates. Hemoglobin. 1997;21(3):237–247.
- Frye RN. Remarks on Baluchi history. Cent Asiatic J. 1961;6:44–50.
- Ashiotis T, Zachariadis Z, Sofroniadou K, Loukopoulos D, Stamatoyannopoulos G. Thalassaemia in Cyprus. Br Med J. 1973;2(5857):38–42.
- Al-Gazali LI, Alwash R, Abdulrazzaq YM. United Arab Emirates: communities and community genetics. Community Genet. 2005;8(3):186–196.
- Belhoul KM, Bakir ML, Saned MS, Kadhim AM, Musallam KM, Taher AT. Serum ferritin levels and endocrinopathy in medically treated patients with β thalassemia major. Ann Hematol. 2012;91(7):1107–1114.